abstract |
Antagonists at the NMDA receptor complex which are benz¢b!azepines of formula (I) having a hydroxy, alkoxy or arnino substituent at the 3-position and a 4-position alkenyl, alkynyl, aryl or heteroaryl substituent for treatment of stroke and/or other neurodegenerative disorders. |